O	0	6	Saliva	Saliva	NN	B-NP
O	7	15	proteins	protein	NNS	I-NP
O	16	18	of	of	IN	B-PP
O	19	25	vector	vector	NN	B-NP
O	26	36	Culicoides	Culicoide	NNS	I-NP
O	37	43	modify	modify	VBP	B-VP
O	44	53	structure	structure	NN	B-NP
O	54	57	and	and	CC	I-NP
O	58	69	infectivity	infectivity	NN	I-NP
O	70	72	of	of	IN	B-PP
O	73	83	bluetongue	bluetongue	JJ	B-NP
O	84	89	virus	virus	NN	I-NP
O	90	99	particles	particle	NNS	I-NP
O	99	100	.	.	.	O

O	101	111	Bluetongue	Bluetongue	NN	B-NP
O	112	117	virus	virus	NN	I-NP
O	118	119	(	(	(	O
O	119	122	BTV	BTV	NN	B-NP
O	122	123	)	)	)	O
O	124	127	and	and	CC	O
O	128	137	epizootic	epizootic	JJ	B-NP
O	138	150	haemorrhagic	haemorrhagic	JJ	I-NP
O	151	158	disease	disease	NN	I-NP
O	159	164	virus	virus	NN	I-NP
O	165	166	(	(	(	O
O	166	170	EHDV	EHDV	NN	B-NP
O	170	171	)	)	)	O
O	172	175	are	be	VBP	B-VP
O	176	183	related	relate	VBN	I-VP
O	184	195	orbiviruses	orbivirus	NNS	B-NP
O	195	196	,	,	,	O
O	197	208	transmitted	transmit	VBN	B-VP
O	209	216	between	between	IN	B-PP
O	217	222	their	their	PRP$	B-NP
O	223	231	ruminant	ruminant	JJ	I-NP
O	232	237	hosts	host	NNS	I-NP
O	238	247	primarily	primarily	RB	B-ADVP
O	248	250	by	by	IN	B-PP
O	251	258	certain	certain	JJ	B-NP
O	259	273	haematophagous	haematophagous	JJ	I-NP
O	274	279	midge	midge	NN	I-NP
O	280	287	vectors	vector	NNS	I-NP
O	288	289	(	(	(	O
O	289	299	Culicoides	Culicoide	NNS	B-NP
O	300	303	spp	spp	NN	I-NP
O	303	304	.	.	.	O
O	304	305	)	)	)	O
O	305	306	.	.	.	O

O	307	310	The	The	DT	B-NP
O	311	317	larger	large	JJR	I-NP
O	318	320	of	of	IN	B-PP
O	321	324	the	the	DT	B-NP
O	325	328	BTV	BTV	NN	I-NP
O	329	334	outer	outer	JJ	I-NP
O	334	335	-	-	HYPH	I-NP
O	335	341	capsid	capsid	NN	I-NP
O	342	350	proteins	protein	NNS	I-NP
O	350	351	,	,	,	O
O	352	353	'	'	``	B-NP
O	353	356	VP2	VP2	NN	I-NP
O	356	357	'	'	''	O
O	357	358	,	,	,	O
O	359	362	can	can	MD	B-VP
O	363	365	be	be	VB	I-VP
O	366	373	cleaved	cleave	VBN	I-VP
O	374	376	by	by	IN	B-PP
O	377	386	proteases	protease	NNS	B-NP
O	387	388	(	(	(	O
O	388	397	including	include	VBG	B-PP
O	398	405	trypsin	trypsin	NN	B-NP
O	406	408	or	or	CC	O
O	409	421	chymotrypsin	chymotrypsin	NN	B-NP
O	421	422	)	)	)	O
O	422	423	,	,	,	O
O	424	431	forming	form	VBG	B-VP
O	432	442	infectious	infectious	JJ	B-NP
O	443	451	subviral	subviral	JJ	I-NP
O	452	461	particles	particle	NNS	I-NP
O	462	463	(	(	(	O
O	463	467	ISVP	ISVP	NN	B-NP
O	467	468	)	)	)	O
O	469	474	which	which	WDT	B-NP
O	475	479	have	have	VBP	B-VP
O	480	488	enhanced	enhance	VBN	I-VP
O	489	500	infectivity	infectivity	NN	B-NP
O	501	504	for	for	IN	B-PP
O	505	510	adult	adult	JJ	B-NP
O	511	521	Culicoides	Culicoide	NNS	I-NP
O	521	522	,	,	,	O
O	523	525	or	or	CC	O
B-Cell	526	528	KC	KC	NN	B-NP
I-Cell	529	534	cells	cell	NNS	I-NP
O	535	536	(	(	(	O
O	536	537	a	a	DT	B-NP
B-Cell	538	542	cell	cell	NN	I-NP
I-Cell	542	543	-	-	HYPH	O
I-Cell	543	547	line	line	NN	B-NP
O	548	555	derived	derive	VBN	B-VP
O	556	560	from	from	IN	B-PP
O	561	562	C	C	NN	B-NP
O	562	563	.	.	.	O
O	564	574	sonorensis	sonorensis	NN	B-NP
O	574	575	)	)	)	O
O	575	576	.	.	.	O

O	577	579	We	We	PRP	B-NP
O	580	591	demonstrate	demonstrate	VBP	B-VP
O	592	596	that	that	IN	B-SBAR
O	597	600	VP2	VP2	NN	B-NP
O	601	608	present	present	JJ	B-ADJP
O	609	611	on	on	IN	B-PP
O	612	620	purified	purify	VBN	B-NP
O	621	626	virus	virus	NN	I-NP
O	627	636	particles	particle	NNS	I-NP
O	637	641	from	from	IN	B-PP
O	642	643	3	3	CD	B-NP
O	644	653	different	different	JJ	I-NP
O	654	657	BTV	BTV	NN	I-NP
O	658	665	strains	strain	NNS	I-NP
O	666	669	can	can	MD	B-VP
O	670	674	also	also	RB	I-VP
O	675	677	be	be	VB	I-VP
O	678	685	cleaved	cleave	VBN	I-VP
O	686	688	by	by	IN	B-PP
O	689	698	treatment	treatment	NN	B-NP
O	699	703	with	with	IN	B-PP
O	704	710	saliva	saliva	NN	B-NP
O	711	715	from	from	IN	B-PP
O	716	721	adult	adult	JJ	B-NP
O	722	732	Culicoides	Culicoide	NNS	I-NP
O	732	733	.	.	.	O

O	734	737	The	The	DT	B-NP
O	738	744	saliva	saliva	NN	I-NP
O	745	753	proteins	protein	NNS	I-NP
O	754	758	from	from	IN	B-PP
O	759	760	C	C	NN	B-NP
O	760	761	.	.	.	O
O	762	772	sonorensis	sonorensis	NN	B-NP
O	773	774	(	(	(	O
O	774	775	a	a	DT	B-NP
O	776	785	competent	competent	JJ	I-NP
O	786	789	BTV	BTV	NN	I-NP
O	790	796	vector	vector	NN	I-NP
O	796	797	)	)	)	O
O	797	798	,	,	,	O
O	799	806	cleaved	cleave	VBD	B-VP
O	807	810	BTV	BTV	NN	B-NP
O	810	811	-	-	HYPH	B-NP
O	811	814	VP2	VP2	NN	I-NP
O	815	819	more	more	RBR	B-ADVP
O	820	831	efficiently	efficiently	RB	I-ADVP
O	832	836	than	than	IN	B-PP
O	837	842	those	those	DT	B-NP
O	843	847	from	from	IN	B-PP
O	848	849	C	C	NN	B-NP
O	849	850	.	.	.	O
O	851	862	nubeculosus	nubeculosus	NN	B-NP
O	863	864	(	(	(	O
O	864	865	a	a	DT	B-NP
O	866	870	less	less	RBR	I-NP
O	871	880	competent	competent	JJ	I-NP
O	880	881	/	/	SYM	I-NP
O	881	884	non	non	AFX	I-NP
O	884	885	-	-	HYPH	I-NP
O	885	891	vector	vector	NN	I-NP
O	892	899	species	specie	NNS	I-NP
O	899	900	)	)	)	O
O	900	901	.	.	.	O

O	902	917	Electrophoresis	Electrophoresis	NN	B-NP
O	918	921	and	and	CC	I-NP
O	922	926	mass	mass	NN	I-NP
O	927	939	spectrometry	spectrometry	NN	I-NP
O	940	950	identified	identify	VBD	B-VP
O	951	952	a	a	DT	B-NP
O	953	960	trypsin	trypsin	NN	I-NP
O	960	961	-	-	HYPH	B-NP
O	961	965	like	like	JJ	I-NP
O	966	974	protease	protease	NN	I-NP
O	975	977	in	in	IN	B-PP
O	978	979	C	C	NN	B-NP
O	979	980	.	.	.	O
O	981	991	sonorensis	sonorensis	NN	B-NP
O	992	998	saliva	saliva	NN	I-NP
O	998	999	,	,	,	O
O	1000	1005	which	which	WDT	B-NP
O	1006	1009	was	be	VBD	B-VP
O	1010	1023	significantly	significantly	RB	I-VP
O	1024	1031	reduced	reduce	VBN	I-VP
O	1032	1034	or	or	CC	O
O	1035	1041	absent	absent	JJ	B-ADJP
O	1042	1046	from	from	IN	B-PP
O	1047	1048	C	C	NN	B-NP
O	1048	1049	.	.	.	O
O	1050	1061	nubeculosus	nubeculosus	NN	B-NP
O	1062	1068	saliva	saliva	NN	I-NP
O	1068	1069	.	.	.	O

O	1070	1080	Incubating	Incubate	VBG	B-VP
O	1081	1089	purified	purify	VBN	B-NP
O	1090	1093	BTV	BTV	NN	I-NP
O	1093	1094	-	-	HYPH	B-NP
O	1094	1095	1	1	CD	I-NP
O	1096	1100	with	with	IN	B-PP
O	1101	1102	C	C	NN	B-NP
O	1102	1103	.	.	.	O
O	1104	1114	sonorensis	sonorensis	NN	B-NP
O	1115	1121	saliva	saliva	NN	I-NP
O	1122	1130	proteins	protein	NNS	I-NP
O	1131	1135	also	also	RB	B-ADVP
O	1136	1145	increased	increase	VBD	B-VP
O	1146	1151	their	their	PRP$	B-NP
O	1152	1163	infectivity	infectivity	NN	I-NP
O	1164	1167	for	for	IN	B-PP
B-Cell	1168	1170	KC	KC	NN	B-NP
I-Cell	1171	1176	cells	cell	NNS	I-NP
O	1177	1178	~	~	VBP	B-VP
O	1178	1180	10	10	CD	B-NP
O	1181	1185	fold	fold	RB	I-NP
O	1185	1186	,	,	,	O
O	1187	1192	while	while	IN	B-SBAR
O	1193	1204	infectivity	infectivity	NN	B-NP
O	1205	1208	for	for	IN	B-PP
B-Cell	1209	1212	BHK	BHK	NN	B-NP
I-Cell	1213	1218	cells	cell	NNS	I-NP
O	1219	1222	was	be	VBD	B-VP
O	1223	1230	reduced	reduce	VBN	I-VP
O	1231	1233	by	by	IN	B-PP
O	1234	1235	2	2	CD	B-NP
O	1235	1236	-	-	HYPH	I-NP
O	1236	1237	6	6	CD	I-NP
O	1238	1242	fold	fold	RB	B-ADVP
O	1242	1243	.	.	.	O

O	1244	1253	Treatment	Treatment	NN	B-NP
O	1254	1256	of	of	IN	B-PP
O	1257	1259	an	an	DT	B-NP
O	1260	1261	'	'	``	I-NP
O	1261	1268	eastern	eastern	JJ	I-NP
O	1268	1269	'	'	''	I-NP
O	1270	1276	strain	strain	NN	I-NP
O	1277	1279	of	of	IN	B-PP
O	1280	1284	EHDV	EHDV	NN	B-NP
O	1284	1285	-	-	HYPH	O
O	1285	1286	2	2	CD	B-NP
O	1287	1291	with	with	IN	B-PP
O	1292	1298	saliva	saliva	NN	B-NP
O	1299	1307	proteins	protein	NNS	I-NP
O	1308	1310	of	of	IN	B-PP
O	1311	1317	either	either	DT	B-NP
O	1318	1319	C	C	NN	I-NP
O	1319	1320	.	.	.	O
O	1321	1331	sonorensis	sonorensis	NN	B-NP
O	1332	1334	or	or	CC	I-NP
O	1335	1336	C	C	NN	I-NP
O	1336	1337	.	.	.	I-NP
O	1338	1349	nubeculosus	nubeculosus	NN	I-NP
O	1350	1357	cleaved	cleave	VBD	B-VP
O	1358	1361	VP2	VP2	NN	B-NP
O	1361	1362	,	,	,	O
O	1363	1366	but	but	CC	O
O	1367	1368	a	a	DT	B-NP
O	1369	1370	'	'	``	I-NP
O	1370	1377	western	western	NN	I-NP
O	1377	1378	'	'	POS	B-NP
O	1379	1385	strain	strain	NN	I-NP
O	1386	1388	of	of	IN	B-PP
O	1389	1393	EHDV	EHDV	NN	B-NP
O	1393	1394	-	-	HYPH	B-NP
O	1394	1395	2	2	CD	I-NP
O	1396	1404	remained	remain	VBD	B-VP
O	1405	1415	unmodified	unmodified	JJ	B-ADJP
O	1415	1416	.	.	.	O

O	1417	1422	These	These	DT	B-NP
O	1423	1430	results	result	NNS	I-NP
O	1431	1439	indicate	indicate	VBP	B-VP
O	1440	1444	that	that	IN	B-SBAR
O	1445	1456	temperature	temperature	NN	B-NP
O	1456	1457	,	,	,	O
O	1458	1464	strain	strain	NN	B-NP
O	1465	1467	of	of	IN	B-PP
O	1468	1473	virus	virus	NN	B-NP
O	1474	1477	and	and	CC	O
O	1478	1485	protein	protein	NN	B-NP
O	1486	1497	composition	composition	NN	I-NP
O	1498	1500	of	of	IN	B-PP
O	1501	1511	Culicoides	Culicoides	NNP	B-NP
O	1512	1518	saliva	saliva	NN	I-NP
O	1519	1520	(	(	(	O
O	1520	1532	particularly	particularly	RB	B-ADVP
O	1533	1536	its	its	PRP$	B-NP
O	1537	1545	protease	protease	NN	I-NP
O	1546	1553	content	content	NN	I-NP
O	1554	1559	which	which	WDT	B-NP
O	1560	1562	is	be	VBZ	B-VP
O	1563	1572	dependent	dependent	JJ	B-ADJP
O	1573	1577	upon	upon	IN	B-PP
O	1578	1584	vector	vector	NN	B-NP
O	1585	1592	species	specie	NNS	I-NP
O	1592	1593	)	)	)	O
O	1593	1594	,	,	,	O
O	1595	1598	can	can	MD	O
O	1599	1602	all	all	DT	O
O	1603	1607	play	play	VB	B-VP
O	1608	1609	a	a	DT	B-NP
O	1610	1621	significant	significant	JJ	I-NP
O	1622	1626	role	role	NN	I-NP
O	1627	1629	in	in	IN	B-PP
O	1630	1633	the	the	DT	B-NP
O	1634	1644	efficiency	efficiency	NN	I-NP
O	1645	1647	of	of	IN	B-PP
O	1648	1651	VP2	VP2	NN	B-NP
O	1652	1660	cleavage	cleavage	NN	I-NP
O	1660	1661	,	,	,	O
O	1662	1673	influencing	influence	VBG	B-VP
O	1674	1679	virus	virus	NN	B-NP
O	1680	1691	infectivity	infectivity	NN	I-NP
O	1691	1692	.	.	.	O

O	1693	1699	Saliva	Saliva	NN	B-NP
O	1700	1702	of	of	IN	B-PP
O	1703	1710	several	several	JJ	B-NP
O	1711	1716	other	other	JJ	I-NP
O	1717	1726	arthropod	arthropod	NN	I-NP
O	1727	1734	species	specie	NNS	I-NP
O	1735	1738	has	have	VBZ	B-VP
O	1739	1749	previously	previously	RB	I-VP
O	1750	1754	been	be	VBN	I-VP
O	1755	1760	shown	show	VBN	I-VP
O	1761	1763	to	to	TO	I-VP
O	1764	1772	increase	increase	VB	I-VP
O	1773	1785	transmission	transmission	NN	B-NP
O	1785	1786	,	,	,	I-NP
O	1787	1798	infectivity	infectivity	NN	I-NP
O	1799	1802	and	and	CC	I-NP
O	1803	1812	virulence	virulence	NN	I-NP
O	1813	1815	of	of	IN	B-PP
O	1816	1823	certain	certain	JJ	B-NP
O	1824	1835	arboviruses	arbovirus	NNS	I-NP
O	1835	1836	,	,	,	O
O	1837	1839	by	by	IN	B-PP
O	1840	1850	modulating	modulate	VBG	B-VP
O	1851	1854	and	and	CC	O
O	1854	1855	/	/	SYM	B-NP
O	1855	1857	or	or	CC	O
O	1858	1869	suppressing	suppress	VBG	B-VP
O	1870	1873	the	the	DT	B-NP
O	1874	1883	mammalian	mammalian	JJ	I-NP
O	1884	1890	immune	immune	JJ	I-NP
O	1891	1899	response	response	NN	I-NP
O	1899	1900	.	.	.	O

O	1901	1904	The	The	DT	B-NP
O	1905	1913	findings	finding	NNS	I-NP
O	1914	1923	presented	present	VBN	B-VP
O	1924	1928	here	here	RB	B-ADVP
O	1928	1929	,	,	,	O
O	1930	1937	however	however	RB	B-ADVP
O	1937	1938	,	,	,	O
O	1939	1950	demonstrate	demonstrate	VBP	B-VP
O	1951	1952	a	a	DT	B-NP
O	1953	1958	novel	novel	JJ	I-NP
O	1959	1968	mechanism	mechanism	NN	I-NP
O	1969	1971	by	by	IN	B-PP
O	1972	1977	which	which	WDT	B-NP
O	1978	1987	proteases	protease	NNS	B-NP
O	1988	1990	in	in	IN	B-PP
O	1991	2001	Culicoides	Culicoides	NNP	B-NP
O	2002	2008	saliva	saliva	NN	I-NP
O	2009	2012	can	can	MD	B-VP
O	2013	2017	also	also	RB	I-VP
O	2018	2026	directly	directly	RB	I-VP
O	2027	2033	modify	modify	VB	I-VP
O	2034	2037	the	the	DT	B-NP
O	2038	2047	orbivirus	orbivirus	NN	I-NP
O	2048	2056	particle	particle	NN	I-NP
O	2057	2066	structure	structure	NN	I-NP
O	2066	2067	,	,	,	O
O	2068	2075	leading	lead	VBG	B-VP
O	2076	2078	to	to	TO	B-PP
O	2079	2088	increased	increase	VBN	B-NP
O	2089	2100	infectivity	infectivity	NN	I-NP
O	2101	2113	specifically	specifically	RB	B-ADVP
O	2114	2117	for	for	IN	B-PP
O	2118	2128	Culicoides	Culicoides	NNP	B-NP
B-Cell	2129	2134	cells	cell	NNS	I-NP
O	2135	2138	and	and	CC	O
O	2138	2139	,	,	,	O
O	2140	2142	in	in	IN	B-PP
O	2143	2147	turn	turn	NN	B-NP
O	2147	2148	,	,	,	O
O	2149	2159	efficiency	efficiency	NN	B-NP
O	2160	2162	of	of	IN	B-PP
O	2163	2175	transmission	transmission	NN	B-NP
O	2176	2178	to	to	TO	B-PP
O	2179	2182	the	the	DT	B-NP
O	2183	2189	insect	insect	NN	I-NP
O	2190	2196	vector	vector	NN	I-NP
O	2196	2197	.	.	.	O

